Otros idiomas Invion Limited

Acciones

IVX

AU000000IVX4

Mercado cerrado - Australian S.E. Otros sitios de cotización 08:10:12 03/05/2024			Varia. Cinco días.	Varia. 1 de enero.
0,005 ^AUD	-16,67 %		-16,67 %	0,00 %

05/03	El fármaco anticanceroso de Invion registra resultados positivos en ensayos preclínicos	MT
27/02	Invion Limited informa de los resultados de ganancias para el semestre finalizado el 31 de diciembre de 2023	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Invion's Anti-Cancer Drug Logs Postive Preclinical Trial Results	05/03
Invion Limited Reports Earnings Results for the Half Year Ended December 31, 2023	27/02
Invion Signs Collaboration Agreement with Dr. I&B Co for HPV Treatment; Shares Up 25%	23/02
Invion Nears Clinical Trial of Cancer Photodynamic Therapy with Drug Substance Production	21/11
Invion Grants RMW Cho Group Right to Distribute Cancer Treatment Products in South Korea	26/09/23
Invion Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31/08/23
Invion Launches New Interactive Investor Hub	11/04/23
Invion Limited agreed to acquire Next Generation Photodynamic Therapy of RMW Cho Group Limited.	06/04/23
Invion Limited Reports Earnings Results for the Half Year Ended December 31, 2022	22/02/23
Invion Expanding Photosoft Technology Rights to US, Canada, Hong Kong	08/02/23
Invion Limited Announces Vitro Test Results on Photosoft	26/10/22
Invion Limited Announces the Positive Screening Results from in Vitro Studies of PhotosoftTM on the Inhibition of the Dengue Virus	24/10/22
Invion Validates Efficacy of Photodynamic Drug Against Anal Cancer	15/09/22
Invion Limited Announces INV043 Effective Against Anal Cancer Squamous Cell Carcinomas in Vitro	15/09/22
Invion Limited Announces PhotosoftTM Shows Activity Against Zika Virus in Preliminary Assays	08/09/22
Invion Limited Reports Earnings Results for the Full Year Ended June 30, 2022	18/08/22
Invion : Activities Report and Appendix 4C	21/07/22
Invion : Notification regarding unquoted securities - IVX	20/06/22
Invion's Cancer Treatment Patent Application Published	09/06/22
Invion Limited Announces International Patent to Extend IP Protection for Photosoft	08/06/22

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Invion Limited

Acciones

IVX

AU000000IVX4

Otros idiomas

Filtros